Here are some of the major companies whose stocks moved on the week’s news.

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK875.00.

TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk (NVO – Research Report) today. The company’s shares closed ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Award to support the development of molecules to inhibit BamA protein Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of US$610k to Justus Liebig ...

The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.

The head of Ozempic maker Novo Nordisk A/S is among business executives who are meeting the Danish prime minister to discuss ...

Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.